Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells.

Division of Clinical Neurology, University of Nottingham, Nottingham, UK.
Journal of Cellular and Molecular Medicine (Impact Factor: 3.7). 09/2007; 11(5):1129-37. DOI: 10.1111/j.1582-4934.2007.00089.x
Source: PubMed

ABSTRACT Curcumin is a polyphenol derived from the dietary spice turmeric. It possesses diverse anti-inflammatory and anti-cancer properties. Curcumin has been shown to exhibit an inhibitory effect on the production of inflammatory cytokines by human monocytes and has inhibited the animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis (EAE) in association with a decrease in interleukin 12 (IL-12) production and signal transducer and activator of transcription 4 (STAT4) activation. The type I interferon (IFN) IFN-has the ability to suppress IL-12. Both IL-12 and IFN-alpha/beta signal through the activation by phosphorylation of STAT4. Our aim was to investigate the effects of curcumin on the ability of T cells to respond to IL-12 or IFN-alpha/beta. We report that curcumin decreases IL-12-induced STAT4 phosphorylation, IFN-gamma production, and IL-12 Rbeta1 and beta2 expression. IFN-beta-induced STAT4 phosphorylation, IL-10 production and IFN receptor (IFNAR) subunits 1 and 2 expression were enhanced by curcumin. Curcumin increased IFN-alpha-induced IL-10 and IFNAR1 expression. Prior exposure to curcumin decreased IFN-alpha-induced IFNAR2 expression and did not modify the level of IFN-alpha-induced pSTAT4 generation. Thus, the effect of curcumin on STAT4 activation in T cells is dependent upon the stimulus to which the T cells have been exposed.

1 Follower
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is considered an inflammatory and neurodegenerative disease of the central nervous system (CNS) which most often presents as relapsing-remitting episodes. Recent evidence suggests that activated astrocytes play a dual functional role in CNS inflammatory disorders such as MS. In this study, we tried to induce anti-inflammatory functions of astrocytes by curcumin. The effects of curcumin were examined on human a astrocyte cell line (U373-MG) induced by lipopolysaccharide (LPS) in vitro. Matrix metalloproteinase (MMP)-9 activity was assessed by gelatin zymography. Cytokine levels were evaluated by quantitative ELISA method and mRNA expression was measured by real-time PCR. We found that curcumin decreased the release of IL-6 and reduced MMP-9 enzyme activity. It down-regulated MCP-1 mRNA expression too. However, curcumin did not have significant effects on the expression of neurotrophin (NT)-3 and insulin-like growth factor (IGF)-1 mRNAs. Results suggest that curcumin might beneficially affect astrocyte population in CNS neuroinflammatory environment lean to anti-inflammatory response and help to components in respects of CNS repair. Our findings offer curcumin as a new therapeutic agent with the potential of regulating astrocyte-mediated inflammatory diseases in the CNS.
    International Immunopharmacology 07/2014; DOI:10.1016/j.intimp.2014.06.035 · 2.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Type 1 diabetes (T1DM) is a T-cell mediated autoimmune disease that selectively destroys pancreatic β−cells. The only possible cure for T1DM is to control autoimmunity against β−cell specific antigens. We explored whether the natural compound curcumin, with anti-oxidant and anti-inflammatory activities, might down-regulate the T-cell response that destroys pancreatic β cell to improve disease outcome in autoimmune diabetes. We employed two accelerated autoimmune diabetes models: 1) cyclophosphamide (CYP) administration to non-obese diabetic (NOD) mice and 2) adoptive transfer of diabetogenic splenocytes into NODscid mice. Curcumin treatment led to significant delay of disease onset and in some instances prevented autoimmune diabetes by inhibiting pancreatic leukocyte infiltration and preserving insulin expressing cells. To investigate the mechanisms of protection we studied the effect of curcumin on key immune cell populations involved in the pathogenesis of the disease. Curcumin modulates T-lymphocyte response impairing proliferation and IFN−γ production through modulation of T-bet, a key transcription factor for pro-inflammatory Th1 lymphocyte differentiation, both at the transcriptional and translational levels. Also, curcumin reduces NF-κB activation in TCR-stimulated NOD lymphocytes. In addition, curcumin impairs the T-cell stimulatory function of dendritic cells with reduced secretion of pro-inflammatory cytokines and NO, low surface expression of coestimulatory molecules leading to an overall diminished antigen presenting cell activity. These in vitro effects correlated with ex vivo analysis of cells obtained from curcumin-treated mice during the course of autoimmune diabetes. These findings reveal an effective therapeutic effect of curcumin in autoimmune diabetes by its actions on key immune cells responsible for β−cell death.
    Clinical & Experimental Immunology 03/2014; 177(1). DOI:10.1111/cei.12322 · 3.28 Impact Factor


Available from